ロード中...
FLT3 inhibitors in acute myeloid leukemia: Current status and future directions
The receptor tyrosine kinase fms-like tyrosine kinase 3 (FLT3), involved in regulating survival, proliferation and differentiation of hematopoietic stem/progenitor cells, is expressed on acute myeloid leukemia (AML) cells in most patients. Mutations of FLT3 resulting in constitutive signaling are co...
保存先:
| 出版年: | Mol Cancer Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600895/ https://ncbi.nlm.nih.gov/pubmed/28576946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-16-0876 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|